60
270 Life Sciences Private Capital Fund II (Cayman) LP files an open-ended venture capital fund
New fund · Venture capital · Pre-first close · NEW YORK, NY · Form D filed 2026-09-16
Pre-first closeFirst filing by this entityrepeat_fund_numeralOffshore / parallel vehiclePlacement agent engaged
Why now — by persona
Relevant to: Fund administrator, Fund audit & tax, Fund-formation counsel. Lead card pending.
People on the filing
| Samantha Beattie | Executive Officer |
| Stephen Squinto | Executive Officer |
| Gaurav Gupta | Executive Officer |
| N/A 270 Life Sciences Private Capital Fund II GP Ltd. | Director |
| Patrick McGoldrick | Executive Officer |
Signed by Samantha Beattie, Executive Director of the Investment Manager.
Placement agents / sales compensation: J.P. Morgan Securities LLC; J.P. Morgan Institutional Investments Inc.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.